Transient superior oblique paresis after injection of Botulinum Toxin A for facial rejuvenation.
Mihir
M
Kothari
Najeeha
N
Shukri
Abdul
A
Quayyum
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects*; D004172:Diplopia / Q000209:etiology / Q000503:physiopathology; D005133:Eye Movements / Q000187:drug effects*; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000009:adverse effects; D009801:Oculomotor Muscles / Q000187:drug effects / Q000503:physiopathology; D015361:Rhytidoplasty / Q000009:adverse effects / Q000379:methods; D020432:Trochlear Nerve Diseases / Q000139:chemically induced* / Q000150:complications / Q000503:physiopathology; D015348:Vision, Binocular / Q000187:drug effects*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A